DNA Sequencing Market Size, Share & Trends Analysis By Technology (Next Generation Sequencing, Sanger Sequencing, Long Read Sequencing, Single Cell Sequencing), By Product (DNA Sequencing Instruments, DNA Sequencing Consumables, DNA Sequencing Services), By Application (Clinical Sequencing, Genomics Research, Cancer Genomics, Liquid Biopsy, Pharmacogenomics), By End-Use (Hospitals, Research Institutes, Pharmaceutical Companies, Biotech Firms), By Region, And Segment Forecasts, Market Size, Market Share, and Forecast Analysis, 2026 – 2036

Market Overview

According to Novatrends Market Intelligence, the Global DNA Sequencing Market was valued at USD 22.4 billion in 2025 and is anticipated to propel at a growth rate of 18.2% from 2026-2036.

The global DNA sequencing market is one of the fastest-growing sectors in life sciences, driven by the democratization of genomic sequencing through declining costs and advancing next generation sequencing (NGS) platforms. Whole genome sequencing, whole exome sequencing, and targeted DNA sequencing are the primary clinical and research sequencing modalities, while Sanger sequencing remains the gold standard for single-locus validation. Short read sequencing dominates high-throughput applications, while long read sequencing from Pacific Biosciences and Oxford Nanopore is enabling structural variant detection and phased assemblies previously impossible with short reads. Single cell sequencing is revolutionizing cancer biology, immunology, and developmental research. DNA sequencing instruments, DNA sequencing consumables, and associated bioinformatics software represent the three major revenue streams. Clinical sequencing in molecular diagnostics, precision medicine, pharmacogenomics, cancer genomics, and liquid biopsy for circulating tumor DNA detection are transforming clinical oncology. AI in genomics is accelerating genomic sequencing variant interpretation and genomic sequencing data analysis at population scale globally.

Market Dynamics

The market is driven by oncology genomics adoption of cancer genomics for tumor profiling and targeted therapy selection, growing liquid biopsy clinical utility in early cancer detection and treatment monitoring, and precision medicine programs integrating pharmacogenomics for drug response prediction. DNA sequencing platforms are becoming clinical laboratory standard equipment as clinical sequencing costs approach routine diagnostic test economics. Bioinformatics and AI in genomics cloud platforms are scaling genomic data interpretation to clinical throughput. In January 2024, Illumina launched its NovaSeq X Plus with $1 per genome sequencing capability targeting whole genome sequencing population studies, while Oxford Nanopore Technologies expanded long read sequencing clinical applications. DNA sequencing consumables revenue is scaling with installed base growth as reagent-dependent NGS workflows generate recurring revenue. Molecular diagnostics adoption of next generation sequencing (NGS) in hospital settings, pharmacogenomics integration in primary care, and single cell sequencing expansion in research are driving DNA sequencing instruments and DNA sequencing consumables demand growth globally.

Segment Analysis

By Technology: Next Generation Sequencing holds the largest share of the DNA Sequencing market, supported by strong adoption and well-established supply chains across key end-use industries. Sanger Sequencing is the fastest-growing segment, propelled by rising investments and expanding application scope in high-growth sectors.

By Product: DNA Sequencing Instruments holds the largest share of the DNA Sequencing market, supported by strong adoption and well-established supply chains across key end-use industries. DNA Sequencing Consumables is the fastest-growing segment, propelled by rising investments and expanding application scope in high-growth sectors.

By Application: Clinical Sequencing holds the largest share of the DNA Sequencing market, supported by strong adoption and well-established supply chains across key end-use industries. Genomics Research is the fastest-growing segment, propelled by rising investments and expanding application scope in high-growth sectors.

Recent Developments in DNA Sequencing Market

• In January 2024, Illumina Inc. launched the NovaSeq X Plus DNA sequencing instruments enabling $1 whole genome sequencing, deploying next generation sequencing (NGS) at population-scale for clinical sequencing, cancer genomics, and genomic sequencing research programs with enhanced bioinformatics and AI in genomics cloud data analysis.
• In April 2024, Oxford Nanopore Technologies advanced long read sequencing and single cell sequencing platforms for clinical sequencing and cancer genomics applications, launching new DNA sequencing consumables and DNA sequencing platforms for molecular diagnostics integration in hospital genomics research settings.
• In July 2024, Pacific Biosciences (PacBio) introduced the Revio long read sequencing system achieving HiFi whole genome sequencing of 1,300+ human genomes annually, targeting precision medicine, pharmacogenomics, and targeted DNA sequencing for rare genetic disease molecular diagnostics and liquid biopsy programs.
• In September 2024, Thermo Fisher Scientific (Ion Torrent) expanded DNA sequencing platforms for clinical sequencing oncology panels, launching cancer genomics liquid biopsy targeted DNA sequencing kits with integrated bioinformatics for hospital-based molecular diagnostics precision medicine programs.
• In December 2024, 10x Genomics launched next-generation single cell sequencing platforms for genomic sequencing and AI in genomics tumor microenvironment research, combining whole exome sequencing with spatial transcriptomics for cancer genomics and drug discovery pharmacogenomics applications.
• In March 2025, Roche Sequencing Solutions advanced short read sequencing and clinical sequencing platforms with new DNA sequencing instruments for hospital molecular diagnostics, integrating AI in genomics variant interpretation and pharmacogenomics decision support for precision medicine oncology and rare disease programs.

Top DNA Sequencing Market - Key Market Players

• Illumina Inc.
• Oxford Nanopore Technologies
• Pacific Biosciences (PacBio)
• Thermo Fisher Scientific
• 10x Genomics
• Roche Sequencing Solutions
• BGI Genomics
• Agilent Technologies
• QIAGEN N.V.
• Eurofins Scientific
• Novogene Co. Ltd.
• Genewiz (Azenta Life Sciences)
• Macrogen Inc.
• Complete Genomics (MGI)
• Element Biosciences

Global DNA Sequencing Market Report- Scope (Customizable)

Detailed Market Segmentation

• By Technology (Revenue in USD Million)
  • Next Generation Sequencing
  • Sanger Sequencing
  • Long Read Sequencing
  • Single Cell Sequencing
• By Product (Revenue in USD Million)
  • DNA Sequencing Instruments
  • DNA Sequencing Consumables
  • DNA Sequencing Services
• By Application (Revenue in USD Million)
  • Clinical Sequencing
  • Genomics Research
  • Cancer Genomics
  • Liquid Biopsy
  • Pharmacogenomics
• By Region (Revenue in USD Million)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Russia
    • Italy
    • Spain
    • Netherlands
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • Central & South America
    • Brazil
    • Argentina
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Turkey
    • Egypt
    • South Africa